Geographic and age variations in mutational processes in colorectal cancer
Marcos Díaz‐Gay(University of California San Diego), Tatsuhiro Shibata(The University of Tokyo), Давид Заридзе(Russian Cancer Research Center NN Blokhin), S. Senkin(Centre international de recherche sur le cancer), Reza Malekzadeh(Tehran University of Medical Sciences), Steven Gallinger(Ontario Institute for Cancer Research), Saamin Cheema(Wellcome Sanger Institute), Samuel Aguiar(AC Camargo Hospital), Jaroslav Kalvach(Charles University), Marko Miladinov(University Clinical Centre), Ahmadreza Niavarani(Tehran University of Medical Sciences), Ivana Holcátová(Charles University), Larry Phouthavongsy(Ontario Institute for Cancer Research), Erik N. Bergstrom(Natera (United States)), Rui Manuel Reis(Hospital de Câncer de Barretos), Katarina Erić(University Clinical Centre), Burçak Otlu(Middle East Technical University), Wellington dos Santos(Centre international de recherche sur le cancer), Denise Peixoto Guimarães(Hospital de Câncer de Barretos), Priscilia Chopard(Centre international de recherche sur le cancer), Ammal Abbasi(University of California San Diego), Katarzyna Roszkowska‐Purska(National Institute of Oncology), Tamara Alejandra Piñero(Hospital Italiano de Buenos Aires), Suleeporn Sangrajrang(National Cancer Institute of Thailand), Valérie Gaborieau(Centre international de recherche sur le cancer), Christopher D. Steele(University of California San Diego), Behnoush Abedi‐Ardekani(Centre international de recherche sur le cancer), Anush Mukeriya(Russian Cancer Research Center NN Blokhin), Ana Carolina de Carvalho(The University of Sydney), Azhar Khandekar(University of California San Diego), Ricardo Cortez Cardoso Penha(Centre international de recherche sur le cancer), Saša Milosavljević, Monique Albert(Ontario Institute for Cancer Research), Raviteja Vangara(University of California San Diego), Luís Gustavo Capochin Romagnolo(Hospital de Câncer de Barretos), Carlos Vaccaro(Hospital Italiano de Buenos Aires), Mariya Kazachkova(University of California San Diego), Calli Latimer(Wellcome Sanger Institute), María Paula Curado(AC Camargo Hospital), Monise Tadin Reis(Hospital de Câncer de Barretos), Thomas Cattiaux(Centre international de recherche sur le cancer), Jingwei Wang(Wellcome Sanger Institute), Sarah Moody(Wellcome Sanger Institute), Stephen Fitzgerald(Wellcome Sanger Institute), Antonio Huertas(Terry Fox Research Institute), Jon W. Teague(Wellcome Sanger Institute), Riley Cox(Ontario Institute for Cancer Research), Beata Świątkowska(Nofer Institute of Occupational Medicine), Christine Carreira(Centre international de recherche sur le cancer), Jolanta Lissowska
Cited by 119
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k